Promising Effect of PDL1 Inhibitors in the front-line management of Primary aggressive Central Nervous System Lymphoma: Case Report
Publication date: Available online 30 June 2020Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Rasha El-Tawab, Aziz Hamada, Rehab Elhagracy, Karen, Salem Alshemmari
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Hematology | Lymphoma | Primary CNS Lymphoma | Stem Cell Therapy | Stem Cells